Utilizing CLIA and EIA strategies all the while, we decided serum HER-2/neu levels a sum of multiple times in 51 patients with metastatic bosom cancer(MBC)and 3 patients with non-intermittent bosom
Utilizing CLIA and EIA strategies all the while, we decided serum HER-2/neu levels a sum of multiple times in 51 patients with metastatic bosom cancer(MBC)and 3 patients with non-intermittent bosom